New cancer drug trial halted early – only 5 patients enrolled
Disease control
Terminated
This early-stage study tested a new drug called HEC89736 in people whose B-cell blood cancers had come back or stopped responding to treatment. The main goals were to check safety, side effects, and how the body processes the drug. Only 5 people took part before the study was sto…
Phase: PHASE1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 19:20 UTC